Shopping Cart
- Remove All
- Your shopping cart is currently empty
UK-396082 is a thrombin-activated fibrinolysis inhibitor (TAFI) that inhibits Carboxypeptidase B. It is used in the study of thrombosis, atherosclerosis, cancer, and fibrotic conditions.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,670 | In Stock | |
50 mg | $2,180 | In Stock | |
100 mg | $2,800 | In Stock |
Description | UK-396082 is a thrombin-activated fibrinolysis inhibitor (TAFI) that inhibits Carboxypeptidase B. It is used in the study of thrombosis, atherosclerosis, cancer, and fibrotic conditions. |
In vitro | UK-396082 induced TAFI activity in NRK52E cells in a dose-dependent manner at concentrations ranging from 0-1000 nM for 96 hours. After 24 hours of treatment at 500 nM, UK-396082 significantly increased fibrinolytic activity in NRK52E cells (109% increase) and also in NRK49F fibroblasts (38.3% increase). In addition, UK-396082 reduced extracellular matrix (ECM) levels in NRK52E cells by 46% under the same conditions (500 nM, 24 hours). [1] |
Alias | UK-396,082 |
Molecular Weight | 239.31 |
Formula | C12H21N3O2 |
Cas No. | 400044-47-5 |
Smiles | C([C@H](CCCN)C(O)=O)C1=CN(CCC)C=N1 |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.